Research Article
Pontin acts as a potential biomarker for poor clinical outcome and promotes tumor invasion in hilar cholangiocarcinoma
Received 26 December 2017; Revised 7 March 2018; Accepted 5 April 2018
Academic Editor: Shinichi Aishima